Biomet decides to explore options for spinning out its 3i dental devices division, following Abbott's lead and Goldman Sachs' advice to another device maker. In a growing trend among device makers, Biomet Inc. announced that it's exploring strategic options to spin out its 3i dental devices division. The company is just testing the waters and a split isn't guaranteed, but if completed the move will follow in some notable footsteps.
